F3 Logic, LLC Dexcom Inc Transaction History

F3 Logic, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 Apr 23, 2021	SELL	$84.79 - $104.74 $47,143 - $58,235	-556 Closed	0 $0
Q4 2020 Feb 12, 2021	SELL	$78.0 - $104.5 $18,954 - $25,393	-243 Reduced 30.41%	556 $203,000
Q3 2020 Nov 13, 2020	SELL	$95.51 - $112.95 $12,034 - $14,231	-126 Reduced 13.62%	799 $329,000
Q2 2020 Aug 10, 2020	BUY	$62.68 - $105.34 $57,979 - $97,439	925 New	925 $369,000

1,019

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $32.6B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of F3 Logic, LLC, based on Form 13F filings with the SEC.

Stay updated on F3 Logic, LLC with notifications on news.